148 related articles for article (PubMed ID: 33331270)
1. Alteration of oral flora in Mongolian patients with Behçet's disease: a multicentre study.
Balt J; Uehara O; Abiko Y; Jamyanjav B; Jav S; Nagasawa T; Mori M; Horie Y; Fujita M; Lennikov A; Ohta T; Hiraoka M; Iwata D; Namba K; Ohno S; Kitaichi N
Clin Exp Rheumatol; 2020; 38 Suppl 127(5):80-85. PubMed ID: 33331270
[TBL] [Abstract][Full Text] [Related]
2. Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.
Novak T; Hamedi M; Bergmeier LA; Fortune F; Hagi-Pavli E
Front Immunol; 2021; 12():724900. PubMed ID: 35003055
[TBL] [Abstract][Full Text] [Related]
3. Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease.
Coit P; Mumcu G; Ture-Ozdemir F; Unal AU; Alpar U; Bostanci N; Ergun T; Direskeneli H; Sawalha AH
Clin Immunol; 2016 Aug; 169():28-35. PubMed ID: 27283393
[TBL] [Abstract][Full Text] [Related]
4. Skin prick test with self-saliva in patients with oral aphthoses: a diagnostic pathergy for Behcet's disease and recurrent aphthosis.
Togashi A; Saito S; Kaneko F; Nakamura K; Oyama N
Inflamm Allergy Drug Targets; 2011 Jun; 10(3):164-70. PubMed ID: 21428910
[TBL] [Abstract][Full Text] [Related]
5. Profiling the microbiome of oral and genital mucosal surfaces in Behçet's disease.
Ogunkolade W; Senusi AA; Desai P; Sacoor S; Bibi A; Gokani B; Sandionigi A; Fortune F
Clin Immunol; 2023 Aug; 253():109654. PubMed ID: 37257548
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of Behcet's disease in Mongolia: a multicenter study.
Balt J; Jamyanjav B; Jav S; Dandii Z; Ganbold C; Horie Y; Lennikov A; Uehara O; Ohno S; Kitaichi N
Clin Rheumatol; 2020 Sep; 39(9):2697-2706. PubMed ID: 32157471
[TBL] [Abstract][Full Text] [Related]
7. A metagenomic study of the gut microbiome in Behcet's disease.
Ye Z; Zhang N; Wu C; Zhang X; Wang Q; Huang X; Du L; Cao Q; Tang J; Zhou C; Hou S; He Y; Xu Q; Xiong X; Kijlstra A; Qin N; Yang P
Microbiome; 2018 Aug; 6(1):135. PubMed ID: 30077182
[TBL] [Abstract][Full Text] [Related]
8. Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD.
Dalghous AM; Freysdottir J; Fortune F
Scand J Rheumatol; 2006; 35(6):472-5. PubMed ID: 17343257
[TBL] [Abstract][Full Text] [Related]
9. Salivary epidermal growth factor levels in Behçet's disease and recurrent aphthous stomatitis.
Adişen E; Aral A; Aybay C; Gürer MA
Dermatology; 2008; 217(3):235-40. PubMed ID: 18663306
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.
Matsuda T; Ohno S; Hirohata S; Miyanaga Y; Ujihara H; Inaba G; Nakamura S; Tanaka S; Kogure M; Mizushima Y
Drugs R D; 2003; 4(1):19-28. PubMed ID: 12568631
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil elastase and endogenous inhibitors in Behçet's disease saliva.
Novak T; Fortune F; Bergmeier L; Khan I; Hagi-Pavli E
Clin Exp Immunol; 2020 Oct; 202(1):93-105. PubMed ID: 32580239
[TBL] [Abstract][Full Text] [Related]
12. Behçet's Disease Under Microbiotic Surveillance? A Combined Analysis of Two Cohorts of Behçet's Disease Patients.
van der Houwen TB; van Laar JAM; Kappen JH; van Hagen PM; de Zoete MR; van Muijlwijk GH; Berbers RM; Fluit AC; Rogers M; Groot J; Hazelbag CM; Consolandi C; Severgnini M; Peano C; D'Elios MM; Emmi G; Leavis HL
Front Immunol; 2020; 11():1192. PubMed ID: 32595645
[No Abstract] [Full Text] [Related]
13. Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study.
Nanke Y; Kamatani N; Okamoto T; Ogiuchi H; Kotake S
Drugs R D; 2008; 9(6):455-9. PubMed ID: 18989994
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between serum IL-9 levels and Behçet's disease.
Nouri-Vaskeh M; Malek Mahdavi A; Khabbazi A; Jadideslam G
Immunol Lett; 2019 Jul; 211():23-27. PubMed ID: 31095970
[TBL] [Abstract][Full Text] [Related]
15. Does hepcidin play a role in the pathogenesis of aphthae in Behçet's disease and recurrent aphthous stomatitis?
Cicek D; Dağlı AF; Aydin S; Baskaya Dogan F; Dertlioğlu SB; Uçak H; Demir B
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1500-6. PubMed ID: 24341321
[TBL] [Abstract][Full Text] [Related]
16. Relationship between periodontal parameters and Behçet's disease and evaluation of different treatments for oral recurrent aphthous stomatitis.
Arabaci T; Kara C; Ciçek Y
J Periodontal Res; 2009 Dec; 44(6):718-25. PubMed ID: 19076988
[TBL] [Abstract][Full Text] [Related]
17. A recurrent aphthous stomatitis case due to paediatric Behçet's disease.
Unal M; Yildirim SV; Akbaba M
J Laryngol Otol; 2001 Jul; 115(7):576-7. PubMed ID: 11485594
[TBL] [Abstract][Full Text] [Related]
18. Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice.
Atienza-Mateo B; Martín-Varillas JL; Graña J; Espinosa G; Moriano C; Pérez-Sandoval T; García-Armario MD; Castellví I; Román-Ivorra JA; Olivé A; Ybáñez A; Martinez-Ferrer A; Narváez J; Romero-Yuste S; Ojeda S; Ros I; Loricera J; Calvo-Río V; Castañeda S; Gonzalez-Gay MA; Blanco R;
Clin Exp Rheumatol; 2020; 38 Suppl 127(5):69-75. PubMed ID: 33331268
[TBL] [Abstract][Full Text] [Related]
19. Platelet indices as a predictor in the differentiation of Behçet's disease from recurrent aphthous stomatitis.
Erturk A; Sari A; Dizen Kazan E; Duran M; Polat SB; Yalcin E; Gok HS; Bozkurt A; Ilgu B; Turan C
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8494-8504. PubMed ID: 37782165
[TBL] [Abstract][Full Text] [Related]
20. The significance of serum nitric oxide levels in Behçet's disease and recurrent aphthous stomatitis.
Yildirim M; Baysal V; Inaloz HS; Doguc D
J Dermatol; 2004 Dec; 31(12):983-8. PubMed ID: 15801262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
